Friday, October 23, 2026

USD/JPY Went Down By Over 2% In The Last 21 Sessions

ViaNews Editorial Team

January 5, 2024

USD/JPY Went Down By Over 2% In The Last 21 Sessions

(VIANEWS) - USD/JPY (USDJPY) has been up by 2.08% for the last 21 sessions. At 10:06 EST on Friday, 5 January, USD/JPY (USDJPY) is $144.12.

Usd/jpy forecast: works against the yen - 05 January 2024

Additionally, keeping a close eye on the 10-year note in the United States is crucial, as it plays a pivotal role in shaping the dynamics of the USD/JPY pair, serving as the most significant secondary market., Should US yields continue their ascent, the USD/JPY pair will likely trend higher.

USD/JPY's yearly highs and lows, it's 13.253% up from its 52-week low and 5.124% down from its 52-week high.

Volatility

USD/JPY's last week, last month's, and last quarter's current intraday variation average was a positive 0.28%, a negative 0.14%, and a positive 0.44%, respectively.

USD/JPY's highest amplitude of average volatility was 0.45% (last week), 0.54% (last month), and 0.44% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/JPY's Forex is considered to be oversold (<=20).

Previous days news about USD/JPY (USDJPY)

  • Usd/jpy soars above the 143.00 figure on US bond yields advance. According to FXStreet on Wednesday, 3 January, "The USD/JPY daily chart depicts the pair as downward biased despite posting a leg-up of more than 140 pips, above the 143.00 figure. ", "Even though the USD/JPY is skyrocketing during Wednesday's session, upside risks remain, with additional US economic data pending to be released. "
  • Usd/jpy analysis: gains May remain cautious - 03 January 2024. According to DailyForex on Wednesday, 3 January, "As trading in 2024 began, the USD/JPY pair attempted to recover, with gains reaching the 142.41 resistance level, which is stable at the time of writing."
  • Usd/jpy hesitates just shy of 143.75. According to FXStreet on Wednesday, 3 January, "The USD/JPY drove higher on Wednesday as the US Dollar (USD), the day's single best-performing currency clambered over the Yen (JPY), the day's biggest loser. ", "The USD/JPY climbed one and a third percent bottom-to-top for the midweek market session, slipping back from just below 143.75 to wrap up Wednesday's trading just above the 143.00 handle."
  • Usd/jpy forecast: recovers from a trendline - 04 January 2024. According to DailyForex on Thursday, 4 January, "The USD/JPY pair is renowned for its inherent volatility, and this characteristic continues to define its behavior. ", "The inherent volatility of the USD/JPY pair, exacerbated by the upcoming jobs report, underscores the need for traders to navigate through market noise. "

More news about USD/JPY (USDJPY).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,475 source documents archived
Query this data → isubstrate.com